Skip to main content
Aurora Cannabis Inc. logo

Aurora Cannabis Inc. — Investor Relations & Filings

Ticker · ACB ISIN · CA05156X8504 TSX Manufacturing
Open in API
Filings indexed 364 across all filing types
Latest filing 2023-10-05 Regulatory Filings
Country CA Canada
Listing TSX ACB

About Aurora Cannabis Inc.

https://www.auroramj.com/

Aurora Cannabis Inc. is a global leader in the production and distribution of cannabis and cannabis-derivative products. The company cultivates and sells a portfolio of products for both medicinal and recreational markets. Recognized as Canada's largest medical cannabis company and a trusted provider, Aurora focuses on innovative, science-based medical cannabis offerings, including dried flower and various derivative formats such as oils and edibles. The company maintains operations across 12 countries, emphasizing high-quality cultivation and rigorous product development to serve patients and consumers worldwide.

Recent filings

Filing Released Lang Actions
Material change report - English.pdf
Regulatory Filings Classification · 95% confidence The document is titled 'Form 51-102F3 Material Change Report' and details a material change event dated October 3, 2023, involving the closing of a bought deal offering of common shares by Aurora Cannabis Inc. It includes specifics about the offering, proceeds, and intended use of funds. The form number 51-102F3 is a regulatory filing used in Canadian securities regulation to report material changes. The content is focused on a financing event and is a formal disclosure of a material change rather than a full financial report or earnings release. It is not an annual or interim report, nor a call transcript or management discussion. The document is a regulatory disclosure of a material change event, fitting the category of Regulatory Filings (RNS) as it does not constitute a full report but a formal announcement of a material event.
2023-10-05 English
News release - English.pdf
Regulatory Filings
2023-10-03 English
Auditors' consent letter.pdf
Regulatory Filings Classification · 95% confidence The document is a consent letter from KPMG LLP addressed to securities commissions and related to a prospectus supplement for Aurora Cannabis Inc. It references the auditor's report on consolidated financial statements and internal control over financial reporting, dated June 14, 2023. The letter states that KPMG consents to the use of their audit report in the prospectus and confirms no misrepresentations in the incorporated financial information. The document is short (2929 characters) and primarily serves as an auditor's consent for inclusion of their report in a prospectus, not the audit report itself or the financial statements. It does not contain financial data or detailed audit findings but is a regulatory filing related to the prospectus. Therefore, it fits best under Regulatory Filings (RNS) as an auditor's consent letter accompanying a prospectus supplement.
2023-09-29 English
Prospectus (non pricing) supplement (other than ATM) – English.pdf
Capital/Financing Update Classification · 100% confidence The document is titled as a "Prospectus Supplement" to a "Short Form Base Shelf Prospectus" and details a public offering of common shares by Aurora Cannabis Inc. It includes information about the offering price, underwriting agreement, over-allotment option, listing approvals, and legal disclaimers. The content focuses on the terms and conditions of a securities offering, which is a capital raising activity. There is no indication that this document is an annual report, earnings release, or any other type of financial report. It is clearly a detailed announcement related to a financing transaction. Therefore, the document fits the category of Capital/Financing Update (CAP). The document length and detail confirm it is not a brief announcement or a regulatory filing fallback. Confidence is high due to explicit references to underwriting, offering price, and share issuance terms.
2023-09-29 English
Underwriting or agency agreements (or amendment thereto).pdf
Capital/Financing Update Classification · 95% confidence The document is an Underwriting Agreement dated September 29, 2023, related to the sale of common shares by Aurora Cannabis Inc. It discusses the terms of the share offering, regulatory compliance with Canadian Securities Laws, the listing of shares on TSX and Nasdaq, and references to the prospectus and shelf procedures. The document is a legal and financial contract related to capital raising and share issuance, not a financial report or earnings release. It is not an announcement of a report publication but a detailed agreement concerning financing activities. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length and content confirm it is not a brief announcement or a certification but a substantive financing agreement.
2023-09-29 English
Consent letter of issuer's legal counsel.pdf
Regulatory Filings Classification · 95% confidence The document is a letter from a legal firm providing consent related to a prospectus supplement for a short form base shelf prospectus. It references legal opinions and compliance with securities regulations but does not contain financial data, management discussion, or report content. The document is short (1690 characters) and serves as a regulatory compliance communication rather than a financial report or announcement of voting results, management changes, or capital updates. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory documents that do not fit other specific categories.
2023-09-29 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.